Reports for SANDOZ CIPROFLOXACIN / DEXAMETHASONE
Brand name
SANDOZ CIPROFLOXACIN / DEXAMETHASONE
Company Name
SANDOZ CANADA INCORPORATED
|
Drug Identification Number
02506882 |
Ingredients
DEXAMETHASONE CIPROFLOXACIN |
Ingredient Strength
0.1 % 0.3 % |
ATC Code
S02CAS02CA |
ATC Descriptor
CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| SANDOZ CIPROFLOXACIN / DEXAMETHASONE | 7.5ML LDP | Resolved | 2022-02-17 | 2022-04-20 | 155259 |
| SANDOZ CIPROFLOXACIN / DEXAMETHASONE | 7.5ML | Resolved | 2023-01-31 | 2023-03-06 | 182808 |
| SANDOZ CIPROFLOXACIN / DEXAMETHASONE | 7.5ML | Resolved | 2023-03-13 | 2023-03-28 | 186952 |
| SANDOZ CIPROFLOXACIN / DEXAMETHASONE | 7.5ML | Resolved | 2023-12-04 | 2023-12-20 | 212439 |
| SANDOZ CIPROFLOXACIN / DEXAMETHASONE | 7.5ML | Resolved | 2024-01-16 | 2024-01-31 | 216164 |
Showing 1 to 5 of 5
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0